Table 3.
Case reports communicating clinical features and management of patients with ReA during COVID-19 admission
Author | [62] | [63] | [64] | [65] | [66] | [67] | [68] | [69] |
---|---|---|---|---|---|---|---|---|
Age/gender | 50s/male | 37/female | 57/male | 47/male | 30/male | 65/female | 34/male | 39/female |
Time from COVID-19 symptom onset to arthritis | 21 days | 12 days | 15 days | No COVID-19 symptoms, 4 days after exposure to coronavirus disease COVID-19 cases | 14 days | 10 days after cessation of all COVID-19-related symptoms | 16 days | 3 weeks |
Involved joints | Bilateral arthritis in his ankles, mild enthesitis in right Achilles tendon. | Pain and swelling in the right hand. MRI showed tendonitis of multiple extensor tendons | Left wrist, the right shoulder and the bilateral knees | Right knee pain and swelling, and pain at his glans penis. | Right elbow, psoriatic lesions on the extensor surface of both elbows and groin suggestive | Symmetric polyarthritis of ankles, wrists and knee joints; palpable purpura of both calves | Swelling, severe pain and tenderness in his right knee | Tenderness in the PIP joint of the second and third fingers and the DIP joint of the fifth finger of the right hand. Tenderness in the second PIP joint and tenderness, swelling, and decreased range of motion in the DIP joint of the left-hand fifth finger. |
HLA-B27 | Negative | ND | ND | ND | Negative | Positive | ND | ND |
SF characteristics | Mild inflammatory fluid without monosodium urate and calcium pyrophosphate crystals | ND | No crystals | 120 mL of turbid yellow fluid, for which no crystals were seen. | ND | ND | ND | ND |
Synovial fluid RT-PCR for SARS-COVID-19 | ND | ND | Negative | Synovial fluid PCR negative, viral cultures for SARS-COVID-19 negative | ND | ND | ND | ND |
Arthritis management | NSAIDs and intra-articular corticosteroid injection | Voltaren gel, neurontin, and oral dilaudid as needed. | No treatment | Etoricoxib, intra-articular triamcinolone into the knee joint 1 week later when the effusion recurred. | NSAIDs for arthritis and topical steroids for skin lesions | Prednisolone | NSAID and intra articular steroid | celecoxib for two weeks |
Outcome | Treatment of moderate improvement. No further follow-up | 4 weeks follow-up. Pain and tenderness to the hand and wrist had improved, however, she still complained of tenderness to the dorsal aspect of the wrist and hand, especially to the finger joints | The arthritis resolved spontaneously on day 27 | No information | Remission after six weeks | All clinical symptoms and CRP levels immediately regressed after initiating prednisolone | Symptoms of arthritis resolved completely within next 10 days. | pain and swelling disappeared after several days |
CRP, c-reactive protein; MRI, magnetic resonance imaging; NSAIDs, non-steroidal anti-inflammatory drugs; ND, not done; PMN, polymorphonuclear; RT-PCR, reverse transcriptase PCR; SARS-COVID-19, severe acute respiratory syndrome coronavirus 19; DIP, distal interphalangeal joint; PIP, proximal interphalangeal joint